Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
1999-1-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1930
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9792396-Anti-HIV Agents,
pubmed-meshheading:9792396-Drug Resistance, Microbial,
pubmed-meshheading:9792396-HIV,
pubmed-meshheading:9792396-HIV Infections,
pubmed-meshheading:9792396-Humans,
pubmed-meshheading:9792396-Mutation,
pubmed-meshheading:9792396-RNA, Viral,
pubmed-meshheading:9792396-Virus Replication
|
pubmed:year |
1998
|
pubmed:articleTitle |
HIV suppression and risk of drug resistance mutations.
|
pubmed:publicationType |
Letter
|